Shenzhen Salubris Pharmaceuticals Co Ltd (002294) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.045x

Based on the latest financial reports, Shenzhen Salubris Pharmaceuticals Co Ltd (002294) has a cash flow conversion efficiency ratio of 0.045x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥400.70 Million ≈ $58.63 Million USD) by net assets (CN¥8.93 Billion ≈ $1.31 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002294 equity financing ratio to measure how much of total assets are equity-financed.

Shenzhen Salubris Pharmaceuticals Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Shenzhen Salubris Pharmaceuticals Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Shenzhen Salubris Pharmaceuticals Co Ltd to evaluate the quality of earnings relative to operating cash generation.

Shenzhen Salubris Pharmaceuticals Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shenzhen Salubris Pharmaceuticals Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Bachem Holding AG
SW:BANB
0.127x
Gerdau SA ADR
NYSE:GGB
0.028x
YANGTZE OPT.FIB.AND CAB.H
F:1YO
N/A
Black Hills Corporation
NYSE:BKH
0.044x
3SBio Inc
F:83B
0.019x
GREEK O.FOOTB. ADR 1/2
F:GF8A
0.457x
Shenghe Resources Holding Co Ltd
SHG:600392
0.024x
ICL Israel Chemicals Ltd
TA:ICL
0.048x

Annual Cash Flow Conversion Efficiency for Shenzhen Salubris Pharmaceuticals Co Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Shenzhen Salubris Pharmaceuticals Co Ltd from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see Shenzhen Salubris Pharmaceuticals Co Ltd market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥8.75 Billion
≈ $1.28 Billion
CN¥1.19 Billion
≈ $173.59 Million
0.136x +25.52%
2023-12-31 CN¥8.06 Billion
≈ $1.18 Billion
CN¥869.79 Million
≈ $127.28 Million
0.108x -11.28%
2022-12-31 CN¥7.98 Billion
≈ $1.17 Billion
CN¥970.80 Million
≈ $142.06 Million
0.122x -17.36%
2021-12-31 CN¥8.05 Billion
≈ $1.18 Billion
CN¥1.18 Billion
≈ $173.40 Million
0.147x -40.08%
2020-12-31 CN¥5.59 Billion
≈ $818.24 Million
CN¥1.37 Billion
≈ $201.11 Million
0.246x +8.75%
2019-12-31 CN¥6.67 Billion
≈ $975.50 Million
CN¥1.51 Billion
≈ $220.47 Million
0.226x +15.83%
2018-12-31 CN¥6.87 Billion
≈ $1.01 Billion
CN¥1.34 Billion
≈ $196.18 Million
0.195x -17.57%
2017-12-31 CN¥6.16 Billion
≈ $901.18 Million
CN¥1.46 Billion
≈ $213.31 Million
0.237x -9.93%
2016-12-31 CN¥5.46 Billion
≈ $798.98 Million
CN¥1.43 Billion
≈ $209.96 Million
0.263x +16.85%
2015-12-31 CN¥4.70 Billion
≈ $687.12 Million
CN¥1.06 Billion
≈ $154.53 Million
0.225x -13.27%
2014-12-31 CN¥3.79 Billion
≈ $554.32 Million
CN¥982.25 Million
≈ $143.73 Million
0.259x +21.59%
2013-12-31 CN¥3.13 Billion
≈ $458.73 Million
CN¥668.52 Million
≈ $97.83 Million
0.213x +6.65%
2012-12-31 CN¥2.61 Billion
≈ $381.44 Million
CN¥521.21 Million
≈ $76.27 Million
0.200x +56.74%
2011-12-31 CN¥2.13 Billion
≈ $312.36 Million
CN¥272.32 Million
≈ $39.85 Million
0.128x +27.50%
2010-12-31 CN¥1.87 Billion
≈ $272.96 Million
CN¥186.65 Million
≈ $27.31 Million
0.100x +20.96%
2009-12-31 CN¥1.62 Billion
≈ $237.55 Million
CN¥134.28 Million
≈ $19.65 Million
0.083x -72.08%
2008-12-31 CN¥262.90 Million
≈ $38.47 Million
CN¥77.89 Million
≈ $11.40 Million
0.296x -18.02%
2007-12-31 CN¥145.96 Million
≈ $21.36 Million
CN¥52.75 Million
≈ $7.72 Million
0.361x +220.57%
2006-12-31 CN¥106.48 Million
≈ $15.58 Million
CN¥12.00 Million
≈ $1.76 Million
0.113x --

About Shenzhen Salubris Pharmaceuticals Co Ltd

SHE:002294 China Drug Manufacturers - Specialty & Generic
Market Cap
$5.42 Billion
CN¥37.01 Billion CNY
Market Cap Rank
#3368 Global
#446 in China
Share Price
CN¥33.20
Change (1 day)
-0.24%
52-Week Range
CN¥30.15 - CN¥68.30
All Time High
CN¥68.30
About

Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of medicines and medical devices in China. The company offers drugs for various therapeutic fields, such as thrombosis, hypertension and related diseases, osteoporosis, and infections, as well as anti-osteolysis, antiallergic, antiepileptic, and antidepressant medicines. It also develops Sacubit… Read more